Showing results (1-10 of 575) with videos related to
Sort By:
Pageof 58
The Lancet. Oncology|February 1, 2011
New driver mutations in non-small-cell lung cancerWilliam Pao, Nicolas GirardThe American Journal of Surgical Pathology|September 24, 2009
Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastasesNicolas Girard, Charuhas Deshpande, Christopher Lau, et al.Chest|April 21, 2009
Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelinesNicolas Girard, Charuhas Deshpande, Christopher G Azzoli, et al.Current Treatment Options in Oncology|October 15, 2022
New Strategies and Novel Combinations in EGFR TKI-Resistant Non-small Cell Lung CancerNicolas GirardMediastinum (Hong Kong, China)|February 4, 2022
Thymic malignancies: next-generation sequencing as a tool to select patients for targeted therapies and immunotherapies?Nicolas GirardFuture Oncology (London, England)|August 28, 2019
Optimizing outcomes and treatment sequences in EGFR mutation-positive non-small-cell lung cancer: recent updatesNicolas GirardBulletin Du Cancer|June 30, 2015
[Is chemotherapy still an option in oncogene-addicted non-small cell lung cancer? No]Nicolas GirardExpert Review of Anticancer Therapy|October 19, 2013
Antiangiogenic agents and chemotherapy in advanced non-small cell lung cancer: a clinical perspectiveNicolas GirardCurrent Oncology Reports|May 28, 2025
Therapeutic Management of Metastatic Thymoma and Thymic CarcinomaNicolas GirardMed (New York, N.Y.)|September 14, 2024
EGFR-mutated NSCLC: A roadmap to treatment sequencesNicolas GirardPageof 58